newsfilter
← Latest News
GlobeNewswire·

Graybug Vision Reports Preliminary Topline Results from Phase 2b ALTISSIMO Trial

Median time to first supportive therapy was 5 months for GB-102 1mg48% of patients in the GB-102 1 mg arm were rescue-free for at least 6 monthsControl of retinal thickness was consistent across all...